Undisclosed Antiviral Program(s)
RNA Viral Infections (e.g., Coronaviruses, Influenza)
PreclinicalActive
Key Facts
Indication
RNA Viral Infections (e.g., Coronaviruses, Influenza)
Phase
Preclinical
Status
Active
Company
About Clear Creek Bio
Clear Creek Bio is an early-stage biotech venture dedicated to antiviral drug discovery against RNA viruses. Operating from the biotech hub of Cambridge, MA, the company is in the preclinical research phase, building a pipeline of small molecule candidates. As a private entity, it is likely funded by venture capital and grants, positioning itself to tackle significant unmet medical needs in virology. The company's success will hinge on advancing its lead candidates into clinical trials and securing strategic partnerships.
View full company profile